Acquisition by Eric Hsu of 45000 shares of InMed Pharmaceuticals at 0.37 subject to Rule 16b-3

6123 Stock  TWD 57.30  1.30  2.32%   
Slightly above 55% of GrandTech's sophisticated investors are presently thinking to get in. The analysis of current outlook of investing in GrandTech CG Systems suggests that some traders are interested regarding GrandTech's prospects. GrandTech's investing sentiment can be driven by a variety of factors including economic data, GrandTech's earnings reports, geopolitical events, and overall market trends.
GrandTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of GrandTech daily returns and investor perception about the current price of GrandTech CG Systems as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by InMed Pharmaceuticals Officer Sr. Vp, Pre-clinical Resdev. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 45000 employee stock option (right to buy) at 0.37 of InMed Pharmaceuticals by Eric Hsu on 1st of May 2024. This event was filed by InMed Pharmaceuticals with SEC on 2023-12-23. Statement of changes in beneficial ownership - SEC Form 4

GrandTech Fundamental Analysis

We analyze GrandTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GrandTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GrandTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

GrandTech is rated second in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

GrandTech CG Systems Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GrandTech stock to make a market-neutral strategy. Peer analysis of GrandTech could also be used in its relative valuation, which is a method of valuing GrandTech by comparing valuation metrics with similar companies.

Additional Tools for GrandTech Stock Analysis

When running GrandTech's price analysis, check to measure GrandTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GrandTech is operating at the current time. Most of GrandTech's value examination focuses on studying past and present price action to predict the probability of GrandTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GrandTech's price. Additionally, you may evaluate how the addition of GrandTech to your portfolios can decrease your overall portfolio volatility.